SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-21-000091
Filing Date
2021-01-07
Accepted
2021-01-07 11:00:57
Documents
4
Period of Report
2020-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bion_8k.htm 8-K 39729
2 CERTIFICATE OF INCORPORATION bion_ex31.htm EX-3.1 1949
3 bion_ex31img4.jpg GRAPHIC 115731
4 bion_ex31img9.jpg GRAPHIC 69312
  Complete submission text file 0001477932-21-000091.txt   298152
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 60122126512
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

IRS No.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-229399 | Film No.: 21513367
SIC: 8071 Services-Medical Laboratories